Smoking withdrawal symptoms in two weeks of abstinence.
S M Shiffman, M E Jarvik
https://pubmed.ncbi.nlm.nih.gov/827760/Actively Recruiting
Led by The Hong Kong Polytechnic University · Updated on 2026-03-02
90
Participants Needed
5
Research Sites
N/A
Total Duration
People with schizophrenia often have high rates of smoking, which contributes to many health problems including lung and heart diseases. This research evaluates whether Acceptance and Commitment Therapy ACT, a group-based therapy, can help change brain responses related to tobacco cravings and reduce psychotic symptoms. The study uses brain scans fMRI and symptom assessments to understand these effects before treatment, after treatment, and six months later. Participants include 60 smokers with schizophrenia who are not currently in other smoking cessation programs, randomly assigned to either group-based ACT sessions or a usual care smoking cessation program called the 5A model. Another 30 non-smokers with schizophrenia will serve as a control group. The ACT group attends eight face-to-face sessions over four weeks, while the 5A group receives a similar duration intervention based on counseling steps. During the study, researchers will collect brain imaging data and measure smoking cessation success, psychiatric symptoms, nicotine dependence, withdrawal symptoms, psychological flexibility, and medication use at three time points before treatment, after treatment, and six months after treatment. The main outcomes include biochemically confirmed smoking abstinence and changes in psychiatric symptoms and brain activity. The total study duration spans from baseline through six months post-intervention.
CONDITIONS
Effects of Smoking on Network Connectivity in Patients With Schizophrenia Symptoms in Scz Patients
Y
Yim Wah Mak
X
Xuelin Zhang, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
The Hong Kong Polytechnic University
Lead Sponsor
Christian Family Service Centre
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 4 weeks
Participants who smoke will receive one of two smoking cessation interventions: Acceptance and Commitment Therapy (ACT-SC) involving eight group sessions over four weeks, or a 5A model smoking cessation program with equivalent duration and attention. Participants who do not smoke will not receive an intervention.
Twice weekly group sessions for 8 sessions total (1.5 hours each) for ACT-SC; similar schedule for 5A-SC
Duration - 6 months
Participants will be followed for 6 months after the intervention to assess smoking abstinence, psychiatric symptoms, and brain function using fMRI.
3 visits including post-intervention and 6-month follow-up assessments with fMRI and clinical evaluations
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Have more questions? Get in touch with our team for quick support
S M Shiffman, M E Jarvik
https://pubmed.ncbi.nlm.nih.gov/827760/Yim-Wah Mak, Alice-Yuen Loke, Doris Y P Leung
https://pubmed.ncbi.nlm.nih.gov/34640321/Samantha G Farris, Michael J Zvolensky, Angelo M DiBello...
https://pubmed.ncbi.nlm.nih.gov/25642937/S T Tiffany, D J Drobes
https://pubmed.ncbi.nlm.nih.gov/1777741/A Raskin
https://pubmed.ncbi.nlm.nih.gov/3387516/T F Heatherton, L T Kozlowski, R C Frecker...
https://pubmed.ncbi.nlm.nih.gov/1932883/M J Jarvis, H Tunstall-Pedoe, C Feyerabend...
https://pubmed.ncbi.nlm.nih.gov/3661797/The Hong Kong Polytechnic University
Lead Sponsor
Christian Family Service Centre
Collaborating Sponsor